High flow nasal cannula for continuous positive airway pressure weaning in preterm neonates: A single-centre experience

Arun Sasi, Atul Malhotra

Research output: Contribution to journalArticleResearchpeer-review

18 Citations (Scopus)


High flow nasal cannula therapy (HFNC) is an emerging method of non-invasive respiratory support therapy for premature infants. Recent evidence around its safety and efficacy for post-extubation respiratory support is encouraging. However, its effect on long-term respiratory outcomes is not known. The aim of this study is to determine the effect of HFNC on respiratory outcomes (chronic lung disease (CLD), need for home oxygen) when used to wean babies from continuous positive airway pressure (CPAP).
Original languageEnglish
Pages (from-to)199 - 203
Number of pages5
JournalJournal of Paediatrics and Child Health
Issue number2
Publication statusPublished - 2015

Cite this